Ben Stevens
Ben is the editor of Business of Cannabis. Since 2021, he has researched, written, and published the vast majority of the outlet’s content, delivering agenda-setting journalism on regulation, business strategy, and policy across Europe.
Ben Stevens · page 59
- Uncategorized
Die Zahl der Anmeldungen für Cannabisclubs in Deutschland steigt weiter, aber das Wachstum hat sich im September verlangsamt
Die Zahl der Anträge und der erteilten Lizenzen für Cannabis-Social-Clubs in Deutschland hat im September weiter zugenommen, aber das Wachstum hat sich im Vergleich zum Vormonat verlangsamt.
- Adult-Use
Thailand Publishes New Draft Bill To Regulate Cannabis Instead of Ban it Outright
In recent months, Thailand has become a biword for the negative impact of cannabis liberalisation policy without adequate planning and forethought.
- Uncategorized
Future of Nebraska’s Latest Efforts to Legalize Medical Cannabis to be Decided Next Week
The future of Nebraska’s latest attempt to legalize medical cannabis is set to be decided next week by a state court judge.
- Medical
Grow and Integro Clinics Expand Medical Cannabis Access Scheme to Include All UK University Students
Grow Pharma and Integro Medical Clinics are set to expand their flagship medical cannabis access program to all UK university students.
- Uncategorized
Odor of Burnt Cannabis ‘Insufficient to Provide Probable Cause for Vehicle Search’, Illinois Supreme Court Rules
An Illinois Supreme Court decision has ruled that the smell of burnt cannabis is ‘insufficient to provide probable cause for a police officer to search a vehicle without a warrant’.
- Uncategorized
Leveling the Playing Field: How the SAFER Banking Act will Impact Payments in the Cannabis Industry
By Nan Siler, Vice President Payment Operations at Finix The US cannabis industry is a fast-growing space that is expected to reach $100 billion in sales by 2030.
- Press releases
Leva Clinic Merges with Zerenia to Expand Patient Care and Promote Medical Cannabis as a Pain Management Solution
Leva Clinic, the UK’s first fully digital clinic for pain management, is excited to announce its merger with Zerenia Clinic, a leading integrated healthcare provider.
- Markets & Stocks
Synbiotic’s CAGR Forecast at 80%, ECS Botanics to Expand Footprint in Germany, & More from Intercure
Synbiotic [stock_market_widget type=”chart” template=”line” assets=”SBX.DE” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] New research conducted by analysts at NuWays has given German buy-and-build cannabis brand Synbiotic an updated ‘buy’ recommendation.
- Data & Analysis
Medical Cannabis Legalisation Could Save US Billions in Health Insurance Reductions
US companies in states that have moved to legalize medical cannabis have lower average health insurance costs, according to a new study by Leafwell.
- Uncategorized
Wo sind die geplanten Cannabis-Modellprojekte in Deutschland?
Deutschlands lang erwartete “Säule 2” läuft Gefahr, von der Regierung angesichts der anhaltenden politischen Blockaden sowohl im Inland als auch in der EU aufgegeben zu werden.
- Adult-Use
Where Are Germany’s Planned Cannabis Model Projects?
Germany’s long-anticipated ‘Pillar 2’ is in danger of being abandoned by the government amid ongoing political roadblocks both domestically and from the EU.
- Press releases
SOMAÍ Pharmaceuticals Launches in Ireland, Offering the Broadest Range of Cannabis-Based Medicines to Patients
SOMAÍ Pharmaceuticals (“SOMAÍ”), a leading EU-GMP vertically integrated Multi-Country Operator (MCO) company with a global footprint of distribution for the largest and most advanced EU GMP-certified cannabinoid-containing pharmaceutical extract portfolio, is proud to announce its partnership with Georgelle Pharmaceutical Ltd (“Georgelle”), to bring an innovative range of cannabis-based medicines to patients in Ireland.










